Molecular Mechanisms of Antipsychotic-induced Insulin Resistance in Healthy Volunteers
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Olanzapine (Primary)
- Indications Aggression; Bipolar depression; Bipolar disorders; Huntington's disease; Major depressive disorder; Manic episodes; Schizophrenia
- Focus Pharmacodynamics
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.
- 12 Jan 2017 Planned initiation date changed from 1 Jan 2017 to 1 Feb 2017.
- 18 Mar 2016 New trial record